Pacific Biosciences Of California (PACB) Retained Earnings (2010 - 2026)
Pacific Biosciences Of California's quarterly Retained Earnings came in at -$147000.0 in Q1 2026, down 138.58% year-on-year from $381000.0 in Q1 2025, and up 99.99% quarter-over-quarter from -$2.7 billion in Q4 2025.
Pacific Biosciences Of California has reported Retained Earnings for 17 years, with the latest figure at -$147000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 138.58% year-over-year to -$147000.0; the trailing twelve-month figure through Mar 2026 stood at -$147000.0 (down 138.58% YoY), and the FY2025 full-year result was -$2.7 billion, down 25.43% from the prior year.
- Retained Earnings for Q1 2026 stood at -$147000.0, up from -$2.7 billion in the prior quarter.
- The five-year high for Retained Earnings was $381000.0 in Q1 2025, with the low at -$2.7 billion in Q4 2025.
- Average Retained Earnings over 5 years is -$1.1 billion, with a median of -$1.4 billion recorded in 2022.
- Year-over-year, Retained Earnings sank 22849650.0% in 2022 and jumped 151.05% in 2025.
- Tracing PACB's Retained Earnings over 5 years: stood at -$1.5 billion in 2022, then slipped by 20.02% to -$1.8 billion in 2023, then declined by 16.85% to -$2.1 billion in 2024, then dropped by 25.43% to -$2.7 billion in 2025, then surged by 99.99% to -$147000.0 in 2026.
- The last three Retained Earnings figures came in at -$147000.0 (Q1 2026), -$2.7 billion (Q4 2025), and -$2.7 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 49.96 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 32.30 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -398.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -221.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 106.20 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 5.65 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -113.10 Mn |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn | -147,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -147,000.00 |
| Dec 31, 2025 | -2.70 Bn |
| Sep 30, 2025 | -2.65 Bn |
| Jun 30, 2025 | 267,000.00 |
| Mar 31, 2025 | 381,000.00 |
| Dec 31, 2024 | -2.15 Bn |
| Sep 30, 2024 | -2.15 Bn |
| Jun 30, 2024 | -523,000.00 |
| Mar 31, 2024 | -1.92 Bn |
| Dec 31, 2023 | -1.84 Bn |
| Sep 30, 2023 | -1.84 Mn |
| Jun 30, 2023 | -1.69 Bn |
| Mar 31, 2023 | -1.92 Mn |
| Dec 31, 2022 | -1.53 Bn |
| Sep 30, 2022 | -6.26 Mn |
| Jun 30, 2022 | -1.37 Bn |
| Mar 31, 2022 | -1.30 Bn |
| Dec 31, 2021 | -1.09 Mn |
| Jun 30, 2021 | -6,000.00 |
| Mar 31, 2021 | -1.12 Bn |
| Dec 31, 2020 | 85,000.00 |
| Sep 30, 2020 | 118,000.00 |
| Jun 30, 2020 | -1.09 Bn |
| Mar 31, 2020 | -1.07 Bn |
| Dec 31, 2019 | 5,000.00 |
| Sep 30, 2019 | 11,000.00 |
| Jun 30, 2019 | -1.04 Bn |
| Mar 31, 2019 | 6,000.00 |
| Dec 31, 2018 | -982.11 Mn |
| Sep 30, 2018 | -24,000.00 |
| Jun 30, 2018 | -16,000.00 |
| Mar 31, 2018 | -903.72 Mn |
| Dec 31, 2017 | -879.73 Mn |
| Sep 30, 2017 | -2,000.00 |
| Jun 30, 2017 | -836.95 Mn |
| Mar 31, 2017 | -3,000.00 |
| Dec 31, 2016 | 5,000.00 |
| Sep 30, 2016 | 23,000.00 |
| Jun 30, 2016 | 52,000.00 |
| Mar 31, 2016 | -732.52 Mn |
| Dec 31, 2015 | -7,000.00 |
| Sep 30, 2015 | 6,000.00 |
| Jun 30, 2015 | -713.58 Mn |
| Mar 31, 2015 | 16,000.00 |
| Dec 31, 2014 | 9,000.00 |
| Sep 30, 2014 | -662.50 Mn |
| Jun 30, 2014 | -653.34 Mn |
| Mar 31, 2014 | 18,000.00 |
| Dec 31, 2013 | -615.31 Mn |
| Sep 30, 2013 | -598.08 Mn |
| Jun 30, 2013 | -2,000.00 |
| Dec 31, 2012 | -536.02 Mn |
| Mar 31, 2012 | -469.14 Mn |
| Dec 31, 2011 | -441.56 Mn |
| Sep 30, 2011 | -4,000.00 |
| Jun 30, 2011 | -389.45 Mn |
| Dec 31, 2010 | -332.17 Mn |